Earnings
ANAB
23.30
-4.59%
-1.12
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2019-12-31
171.02M
203.21M
--
--
--
--
0.00
--
--
--
3.51M
--
377.73M
3.02M
--
54.30M
--
--
--
--
139.00K
57.46M
435.20M
--
16.24M
0.00
--
--
--
--
--
11.92M
--
--
--
--
29.54M
0.00
--
--
--
654.00K
654.00K
30.19M
27.00K
648.67M
-244.03M
--
--
--
405.01M
405.01M
435.20M
FY 2018-12-31
113.60M
313.49M
--
--
--
--
174.00K
--
--
--
6.96M
--
434.22M
1.45M
--
73.13M
--
--
--
--
208.00K
74.78M
509.00M
--
5.44M
0.00
--
--
--
--
--
8.76M
--
--
--
58.00K
21.84M
625.00K
--
--
--
171.00K
796.00K
22.63M
27.00K
633.25M
-146.69M
--
--
--
486.37M
486.37M
509.00M
FY 2017-12-31
81.19M
167.22M
--
--
--
--
1.60M
--
--
--
2.69M
--
252.70M
665.00K
--
75.90M
--
--
--
--
106.00K
76.67M
329.36M
--
2.32M
0.00
--
--
--
--
--
4.88M
--
--
--
17.00K
14.09M
7.55M
--
--
--
140.00K
7.69M
21.78M
24.00K
393.02M
-85.03M
--
--
--
307.58M
307.58M
329.36M
FY 2016-12-31
51.23M
--
--
5.34M
--
--
5.34M
--
--
--
1.63M
--
58.21M
471.00K
--
--
--
--
--
--
3.50M
3.97M
62.18M
--
2.28M
0.00
--
--
--
--
--
3.43M
--
--
--
1000.00
5.71M
13.81M
--
--
--
3.40M
17.20M
22.91M
3000.00
16.67M
-54.92M
--
--
--
39.27M
39.27M
62.18M
FY 2015-12-31
51.68M
--
--
1.23M
--
--
1.23M
--
--
--
554.00K
--
53.46M
551.00K
--
--
--
--
--
--
2.27M
2.82M
56.28M
--
1.52M
0.00
--
--
--
--
--
2.75M
--
--
--
3.10M
7.38M
4.90M
--
--
--
1.66M
6.57M
13.94M
3000.00
15.48M
-50.66M
--
--
--
42.34M
42.34M
56.28M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out ANAB latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze AnaptysBio recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.